Eudaimonia Partners, LLC Incyte Corp Transaction History

Eudaimonia Partners, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$79.87 - $87.53 $15,974 - $17,506	-200 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$76.02 - $100.5 $15,204 - $20,100	200 New	200 $16,000
Q3 2020 Nov 16, 2020	SELL	$85.07 - $109.69 $17,014 - $21,938	-200 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$74.18 - $108.93 $14,836 - $21,786	200 New	200 $21,000

643

186M

714K

557K

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $16B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

Get notified when there are updates to the investment portfolio of Eudaimonia Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Eudaimonia Partners, LLC with notifications on news.